Allianz Asset Management’s ResMed RMD Stock Holding History

Allianz Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-300	Closed	-$65.7K	–	2265
2023 Q1	$65.7K	Buy	+300	New	+$65.1K	﹤0.01%	2076
2022 Q2	–	Sell	-400	Closed	-$97K	–	2388
2022 Q1	$97K	Buy	+400	New	+$96.8K	﹤0.01%	2343
2021 Q4	–	Sell	-1,200	Closed	-$316K	–	2665
2021 Q3	$316K	Buy	1,200 +300	+33%	+$82K	﹤0.01%	2394
2021 Q2	$222K	Buy	+900	New	+$189K	﹤0.01%	2334
2020 Q3	–	Sell	-1,400	Closed	-$269K	–	2308
2020 Q2	$269K	Sell	1,400 -1,500	-52%	-$245K	﹤0.01%	2222
2020 Q1	$427K	Buy	+2,900	New	+$462K	﹤0.01%	2106

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Allianz Asset Management's RMD Position: Q1 2026 in Review

Allianz Asset Management increased its ResMed (RMD) stake by 4.4% in Q1 2026, buying an estimated $3.25M and bringing the position to 310,802 shares worth $69.8M. The position accounts for 0.07% of the portfolio, ranked #248.

Allianz Asset Management first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $102M in Q1 2025. 940 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Allianz Asset Management held 310,802 shares of ResMed worth $69.8M as of Q1 2026.
Allianz Asset Management bought 13,051 ResMed shares in Q1 2026, an estimated $3.25M.
ResMed made up 0.07% of Allianz Asset Management's portfolio in Q1 2026, its #248 holding.
Allianz Asset Management first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
Allianz Asset Management's ResMed position peaked at $102M in Q1 2025.
940 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.